Louisiana 2012 Regular Session

Louisiana House Bill HR114

Introduced
5/21/12  

Caption

Requests an evaluation by La. officials of efforts to deter prescription drug abuse and recommendations for best practices to combat such abuse

Companion Bills

No companion bills found.

Previously Filed As

LA SR134

Requests evaluation of existing efforts at deterring prescription drug abuse, determination of effectiveness of current efforts, and recommendations on best practices for combating abuse while ensuring access is not restricted for those in need of prescription medications.

LA HCR113

Establishes the Commission on Preventing Opioid Abuse

LA SB533

Provides relative to substance abuse evaluations of persons convicted of DWI.

LA SB323

To establish the Prescription Drug Overdose and Abuse Awareness Fund. (7/1/12) (OR SD RV See Note)

LA AR83

Relative to Prescription Drug Abuse Awareness Month.

LA HB216

Relating To Prescription Drugs.

LA SB226

Relating To Prescription Drugs.

LA HCR96

Requests the Department of Insurance to study the impact of alternative funding programs on patient access to affordable prescription drugs

LA HCR99

Requests a study and recommendations by the Louisiana State Board of Medical Examiners concerning over-prescribing of pain medication

LA SB00431

An Act Concerning Changes To Prescription Drug Abuse Statutes.

Similar Bills

LA SB29

Provides relative to a single uniform prescription drug prior authorization form. (See Act) (RE SEE FISC NOTE SG EX See Note)

LA HB548

Requires that the prescribers transmit prescriptions for opioids to pharmacies electronically (EG SEE FISC NOTE SG EX See Note)

LA HB384

Creates and provides for a state prescription drug importation program (OR INCREASE SG EX See Note)

LA SB59

Provides relative to prescription drug price information. (gov sig)

LA HR181

Urges and requests the Louisiana Department of Health to study the desirability and feasibility of adopting state policy to provide for review of prescription drug prices in the medical assistance program

LA SB496

Provides for limits on certain medical prescriptions. (8/1/14)

LA SCR31

Requests the Department of Economic Development and the Department of Revenue to develop an incentive package that will make Louisiana the domestic prescription drug manufacturing leader for the United States.

LA SR134

Requests evaluation of existing efforts at deterring prescription drug abuse, determination of effectiveness of current efforts, and recommendations on best practices for combating abuse while ensuring access is not restricted for those in need of prescription medications.